Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma — Stella

Home/Adenoid Cystic Carcinoma/Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma

View on ClinicalTrials.gov

Recruiting

Back to Adenoid Cystic Carcinoma trials

Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Shanghai Oriental Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Safety & dosing

Sponsor

HitGen Inc.

Enrollment target

~140 participants

Started

December 2024

Primary completion

December 2028

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.